The global pharmaceutical market is set to surpass a total value of US$1.75 trillion by the end of the decade, according to Evaluate Pharma. Experienced and novice investors alike may want to consider ...

Launched on 06/23/2005, the Invesco Pharmaceuticals ETF (PJP) is a smart beta exchange traded fund offering broad exposure to the Health Care ETFs category of the market. What Are Smart Beta ETFs?

Looking for broad exposure to the Healthcare - Pharma segment of the equity market? You should consider the VanEck Pharmaceutical ETF (PPH), a passively managed exchange traded fund launched on ...

The agreement, announced as part of the broader US-UK Economic Prosperity Deal, secures tariff-free access for more than £5 billion a year in UK pharmaceutical exports to the United States, as ...

Healthcare ETFs stay resilient as Big Pharma agrees to Medicaid drug price cuts. Here's what is cushioning ETFs despite pricing pressure.

The VanEck Pharmaceutical exchange-traded fund is on a strong run this week as news of Pfizer's deal with the Trump administration helped boost pharmaceutical stocks. The ETF was up 1.1% at $94.36 in ...

Investors were reminded Monday that the healthcare sector remains this year’s premiere destination for large-scale mergers and acquisitions activity when Israel’s Teva Pharmaceuticals TEVA agreed to ...

The Invesco Pharmaceuticals ETF (PJP) was launched on June 23, 2005, and is a passively managed exchange traded fund designed to offer broad exposure to the Healthcare - Pharma segment of the equity ...